Lonza Group (XSWX:LONN) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:LONN Lonza Group Ltd XSWX:LONN
85 GF Score
Price CHF562.60
GF Value CHF578.44
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Lonza Group Short-term investments?

Short-term investments only applies to insurance companies.

XSWX:LONN
85GF Score
Lonza Group Ltd XSWX:LONN
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lonza Group (XSWX:LONN) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of CHF562.60 is trading 2.7% below its estimated GF Value™ of CHF578.44. GuruFocus considers Lonza Group to be Fairly Valued.

Key valuation signals for XSWX:LONN:

  • Short-term investments:
  • GF Value™: CHF578.44 vs. price of CHF562.60 (2.7% below fair value)
  • GF Score™: 85/100 with 4 warning signs

No single metric tells the full story. See the XSWX:LONN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
85GF Score

Get the complete analysis for XSWX:LONN

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF562.60
Price
CHF578.44
GF Value